| Literature DB >> 30795767 |
Tsutomu Kumamoto1,2, Junichi Shindoh3, Hideaki Mita4, Yuriko Fujii5, Yuichiro Mihara4, Michiro Takahashi4, Nobuyuki Takemura4, Takako Shirakawa5, Hisashi Shinohara6, Hiroya Kuroyanagi3.
Abstract
BACKGROUND: Prediction of nodal involvement in colorectal cancer is an important aspect of preoperative workup to determine the necessity of preoperative treatment and the adequate extent of lymphadenectomy during surgery. This study aimed to investigate newer multidetector-row computed tomography (MDCT) findings for better predicting lymph node (LN) metastasis in colorectal cancer.Entities:
Keywords: Colorectal cancer; Lymph node metastasis; Multidetector-row computed tomography; Preoperative diagnosis
Mesh:
Year: 2019 PMID: 30795767 PMCID: PMC6387477 DOI: 10.1186/s12957-019-1583-y
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1Extranodal neoplastic spread (ENS): the white arrow indicates a lymph node with ENS
Fig. 2Three-dimensional reconstruction: the size and volume of the lymph node were measured
Baseline patient characteristics
| Characteristic | Value ( |
|---|---|
| Age (years) | 70 (39–95) |
| Male/female ratio | 41/29 |
| Body mass index (kg/m2) (range) | 22.6 (14.1–30.5%) |
| Tumor location | |
| Appendix vermiformis/cecum | 15 (21.4%) |
| Ascending colon | 9 (12.9%) |
| Transverse colon | 8 (11.4%) |
| Descending colon | 3 (4.3%) |
| Sigmoid colon/rectosigmoid colon | 25 (35.7%) |
| Rectum | 10 (14.3%) |
| Depth of tumor | |
| Mucosa | 4 (5.7%) |
| Submucosa | 14 (20.0%) |
| Muscularis propria | 9 (12.9%) |
| Subserosa | 28 (40.0%) |
| Exposure on submucosa or invade other organs or structures | 15 (21.4%) |
| Differentiationa | |
| Well differentiated | 32 (45.7%) |
| Moderately differentiated | 35 (50.0%) |
| Poorly differentiated | 3 (4.3%) |
| Obstructionb | 17 (24.3%) |
| Preoperative intervention | 7 (10.0%) |
| Endoscopic resection | 4 (5.7%) |
| Ileus tube | 3 (4.3%) |
| WBC (/mm3) | 5700 (2600–14,700) |
| NLR | 2.40 (0.01–9.65) |
| CRP (mg/mL) | 0.16 (0.01–6.20) |
| CEA (ng/mL) | 3.6 (0.7–98) |
| CA19-9 (U/L) | 6.0 (0.07–4412) |
| Days from CT to surgery | 20 (2–71) |
| Lymph node enlargement on CT | 46 (65.7%) |
| Pathologically confirmed metastasis | 28 (40.0%) |
Data are presented as median (range) or number (%) unless otherwise indicated
WBC white blood cell, NLR neutrophil to lymphocyte ratio, CRP c-reactive protein, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9, CT computed tomography
aDominant histopathological features of differentiation
bObstruction, which was not passed through with an endoscope
Univariate analyses of clinical factors predicting lymph node enlargement on multidetector computed tomography
| Clinical factor | |
|---|---|
| Age | 0.556 |
| Male/female ratio | 0.630 |
| Body mass index | 0.586 |
| Tumor location (right side vs left side) | 0.623 |
| Differentiation | 0.323 |
| Obstruction | 0.025 |
| Ileus tube | 0.201 |
| Endoscopic resection | 0.077 |
| WBC | 0.004 |
| NLR | 0.138 |
| CRP | 0.204 |
| Pathologically confirmed metastasis | 0.004 |
WBC white blood cell, NLR neutrophil to lymphocyte ratio, CRP c-reactive protein
Fig. 3Receiver operating characteristic curves show the ability of each multidetector computed tomography measurement to predict lymph node metastasis. AUC, area under the curve; 2D, two-dimensional; 3D, three-dimensional; SAD, short-axis diameter; LAD, long-axis diameter; CTmax, maximum computed tomography attenuation value; CTaver, average computed tomography attenuation value; LN, lymph node
Predictive probability for histopathologic metastases in the scoring system generated in this study
| Score | Number of LN metastases (%) | Number of non-LN metastases (%) |
|---|---|---|
| Score 0 | 7 (9.0%) | 71 (91.0%) |
| Score 1 | 16 (27.1%) | 43 (72.9%) |
| Score 2 | 33 (91.7%) | 3 (8.3%) |